Novel approaches for the treatment of Alzheimer's and Parkinson's disease
M Van Bulck, A Sierra-Magro, J Alarcon-Gil… - International journal of …, 2019 - mdpi.com
Neurodegenerative disorders affect around one billion people worldwide. They can arise
from a combination of genomic, epigenomic, metabolic, and environmental factors. Aging is …
from a combination of genomic, epigenomic, metabolic, and environmental factors. Aging is …
Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases
VS Gontijo, FPD Viegas, CJC Ortiz… - Current …, 2020 - ingentaconnect.com
Neurodegenerative Diseases (NDs) are progressive multifactorial neurological pathologies
related to neuronal impairment and functional loss from different brain regions. Currently, no …
related to neuronal impairment and functional loss from different brain regions. Currently, no …
Merged tacrine-based, multitarget-directed acetylcholinesterase inhibitors 2015–present: Synthesis and biological activity
TJ Eckroat, DL Manross, SC Cowan - International journal of molecular …, 2020 - mdpi.com
Acetylcholinesterase is an important biochemical enzyme in that it controls acetylcholine-
mediated neuronal transmission in the central nervous system, contains a unique structure …
mediated neuronal transmission in the central nervous system, contains a unique structure …
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects
J Brtko - Archiv der Pharmazie, 2022 - Wiley Online Library
This review traces the road leading to the demonstration of a variety of kojic acid chemical
and biological properties. It illustrates the biological effects of several synthetic kojic acid …
and biological properties. It illustrates the biological effects of several synthetic kojic acid …
Tacrines as therapeutic agents for alzheimer's disease. V. recent developments
ÓM Bautista‐Aguilera, L Ismaili, I Iriepa… - The Chemical …, 2021 - Wiley Online Library
Herein we have reviewed our recent developments for the identification of new tacrine
analogues for Alzheimer's disease (AD) therapy. Tacrine, the first cholinesterase inhibitor …
analogues for Alzheimer's disease (AD) therapy. Tacrine, the first cholinesterase inhibitor …
Design, synthesis and biological assessment of acridine derivatives containing 1, 3, 4-thiadiazole moiety as novel selective acetylcholinesterase inhibitors
A novel series of acridine derivatives containing substituted thiadiazol-2-amine moiety was
synthesized via multi-component condensation reaction of dimedone, aromatic aldehyde …
synthesized via multi-component condensation reaction of dimedone, aromatic aldehyde …
Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2)
Multidrug resistance constitutes a serious obstacle of the treatment success of cancer by
chemotherapy. Mostly it is driven by expression of ABC transport proteins that actively efflux …
chemotherapy. Mostly it is driven by expression of ABC transport proteins that actively efflux …
Therapeutic potential of multifunctional derivatives of cholinesterase inhibitors
M Przybyłowska, K Dzierzbicka… - Current …, 2021 - benthamdirect.com
The aim of this work is to review tacrine analogues from the last three years, which were not
included in the latest review work, donepezil and galantamine hybrids from 2015 and …
included in the latest review work, donepezil and galantamine hybrids from 2015 and …
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 …
R Malek, A Simakov, A Davis, M Maj, PJ Bernard… - Molecules, 2022 - mdpi.com
Novel multitarget-directed ligands BIGI 4a-d and BIGI 5a-d were designed and synthesized
with a simple and cost-efficient procedure via a one-pot three-component Biginelli reaction …
with a simple and cost-efficient procedure via a one-pot three-component Biginelli reaction …
Critical evaluation of current Alzheimer's drug discovery (2018–19) & futuristic Alzheimer drug model approach
A Dorababu - Bioorganic Chemistry, 2019 - Elsevier
Abstract Alzheimer′ s disease (AD), a neurodegenerative disease responsible for death of
millions of people worldwide is a progressive clinical disorder which causes neurons to …
millions of people worldwide is a progressive clinical disorder which causes neurons to …